[INM] YoY Quarter Result on 31-Mar-2022 [#Q3]

Stock
[INM] InMed Pharmaceuticals Inc.
Announcement Date
13-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q3]
Profit Trend
QoQ- 18.84%
YoY- -12.09%
Quarter Report
INM's Result
INM's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 1,173 1,034 310 0 0 0 0 -
PBT -1,723 -1,996 -3,476 -3,101 -1,979 -2,614 -1,648 0.74%
Tax -0 2 -31 -28 -165 -27 -22 -
NP -1,723 -1,998 -3,476 -3,101 -2,024 -2,614 -1,648 0.74%
Tax Rate - - - - - - - -
Total Cost 2,895 3,032 3,785 3,101 2,024 2,614 1,648 9.83%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -146.93 -193.24 -1,122.69 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.18 -0.60 -6.14 -10.27 -9.69 -12.59 -8.97 -47.83%
EPS Diluted -0.18 -0.60 -6.14 -10.27 -9.69 -12.59 -8.97 -47.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.